5th MIT-CMAC International Symposium on Continuous Manufacturing of Pharmaceuticals

An Integrated Ecosystem for Transforming Medicines Manufacturing

February’s meeting, jointly run between MIT and CMAC Future Manufacturing Research Hub, brought together over 350 pharmaceutical industrialists, regulators, policy makers and academics from more than 22 countries and 142 organisations to inform strategies to grow medicines manufacturing in the UK and internationally, through accelerating the adoption of advanced manufacturing and digital technologies.

Recommendations 

The UK already benefits from an excellent research base, investments in innovation centres, leading pharmaceutical manufacturers, dynamic technology and supply chain partners and a leading, independent national regulator, the MHRA. Given the strategic importance and opportunities for growth in the medicines manufacturing sector, a number of recommendations are made to strengthen the UK’s position as a leading location to develop, design, manufacture and supply medicines.

Summary Document

The full document and recommendations across industry, academia and regulatory can be viewed here.

This meeting was hosted by the joint MIT CMAC ISCMP Steering Team. Registration and attendance was at no charge to participants.